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Purpose To identify the frequencies of orofacial manifestations documented in the U.S. population of Lyme disease
Lyme Disease
Most common vector-borne disease in the U.S.
First recognized in the 1970s
Caused by a bite from an infected Ixodes scapularis, commonly known as a 
deer tick or blacklegged tick, carrying the bacterium Borrelia burgdorferi
The bacterium is transferred to human hosts through a blood meal of an 
infected tick
Methods
Four electronic databases were systematically searched by the university's health and life sciences librarian 
from May 2019 to October 2019.
Several search term alterations were used and synonyms for the key search terms were cross-checked 
using the U.S. National Library of Medicine Unified Medical Language System.
Retrieved articles were independently reviewed for relevance based on titles and abstracts.
Risk of bias was assessed independently, and data extraction was completed using a modified version of 
the Cochrane Data Collection Form for Randomized Control Trials and Non-randomized Control Trials.
Meetings were held to resolve disagreements by consensus.
Methods Cont.
• Studies that included populations from the U.S.
• Available in full-text and in the English language
• Confirmed CDC diagnosis of Lyme disease 
Inclusion Criteria:
• Studies of foreign populations
• Studies involving animal subjects
• Tick-borne diseases other than Lyme disease





 Facial palsy 
 Temporomandibular joint (TMJ) arthralgia 
 Altered taste 
 Stiff neck 
 Sore throat 
 Neck pain/arthralgia 
 Erythema migrans rash on the head or neck

























Endemic states where Lyme 
disease was reported in patients
• Delaware (n=3, 25%)
• Massachusetts (n=4, 33%)
• Pennsylvania (n=2, 17%)
• New Jersey (n=1, 8%)
• Connecticut (n=3, 25%)









Observational design 5 42%
Results Cont.
Results Cont.
In five articles they appeared only slightly less (n=5, 42%).
In one article they appeared the same number of times (n=1, 8%).
In half of the articles (n=6, 50%), the frequency of orofacial manifestations 
appeared more than the total number of patients with confirmed Lyme disease.
 Nine out of the twelve articles (75%), included mostly males while only two 
articles reported predominantly on female populations. One article did not 
make the distinction clear.
 Six articles included a mixture of ages from childhood to adulthood (n=6, 
50%), four included children and adolescents (n=4, 33%),and one focused only 
on adults (n=1, 8%).
Results Cont.
Discussion
 New research is needed in order to have a better understanding of this topic.
 None of the included articles discussed assessments or scales that could be 
used to quantify orofacial manifestations.  
 None of the included articles came from journals whose target audience is in 
the dental profession.
Discussion Cont.
Less than half (6 out of 14) of the endemic states were represented by the articles.  
The literature also did not report orofacial manifestations evenly across demographics. 
An underrepresentation of females could be a concern especially for those residing in low 
incidence states since Lyme disease has been found to be more common among females 
there.
Since half of the articles reported more orofacial manifestations than the total number of 
research participants, orofacial manifestations should be highly considered in clinical 
diagnoses, especially since they can occur during the localized early stage when serology 
testing may fail.
Conclusion
Current research regarding the orofacial manifestations of Lyme disease is 
needed so that the medical phenomenon can be well understood by healthcare 
professionals in order to best serve their patients.
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